Adaptive Pharmacogenomics, LLC

In two papers published on Dec. 2 in the open-access scientific journal PLoS One, researchers at SomaLogic Inc. and their collaborators describe a revolutionary new approach to biomarker detection and demonstrate its potential diagnostic power in a large-scale study that identifies a panel of biomarkers that can detect lung cancer in its early -- and treatable -- stages.